FDA Inspection 886530 — Zhejiang Huahai Pharmaceutical

Zhejiang Huahai Pharmaceutical — FEI 3003885745

The FDA completed an inspection of Zhejiang Huahai Pharmaceutical on May 23, 2014 in Linhai. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
May 23, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Linhai (China)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.